Showing results (71-80 of 224) with videos related to
Sort By:
Pageof 23
Fertility and Sterility|March 2, 2002
Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndromeC J Glueck, Ping Wang, Suichi Kobayashi, et al.Metabolism: Clinical and Experimental|December 1, 1980
Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptivesT P Wynne, M A Frey, L L Laubach, et al.Circulation|August 1, 1978
Value and safety of diet modification to control hyperlipidemia in childhood and adolescence. A statement for physicians. Ad Hoc Committee of the Steering Committee for Medical and Community Program of the American Heart AssociationC J Glueck, H C McGill, R E Shank, et al.Fertility and Sterility|February 13, 2001
Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot studyC J Glueck, H Phillips, D Cameron, et al.Metabolism: Clinical and Experimental|May 1, 1994
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyE M Velazquez, S Mendoza, T Hamer, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
Measurement of plasminogen activator inhibitor type 1 antigen: comparison of Tintelize and Imubind methodsD M Stroop, C J Glueck, T M Tracy, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndromeC J Glueck, S Bornovali, J Pranikoff, et al.Metabolism: Clinical and Experimental|December 3, 1999
Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patientsC J Glueck, J E Lang, T Tracy, et al.Clinical Orthopaedics and Related Research|May 12, 2001
Hypofibrinolysis, thrombophilia, osteonecrosisC J Glueck, R A Freiberg, R N Fontaine, et al.The American Journal of Cardiology|May 21, 1999
Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular diseaseC J Glueck, J E Lang, T Tracy, et al.Pageof 23